Sign In
Buy EVLV
Evolv Technologies Holdings Earnings Calls
| Release date | May 12, 2026 |
| EPS estimate | -$0.0600 |
| EPS actual | -$0.0300 |
| EPS Surprise | 50.00% |
| Revenue estimate | 44.226M |
| Revenue actual | 46.328M |
| Revenue Surprise | 4.75% |
| Release date | Mar 10, 2026 |
| EPS estimate | -$0.0800 |
| EPS actual | $0.0600 |
| EPS Surprise | 175.00% |
| Revenue estimate | 36.453M |
| Revenue actual | 38.504M |
| Revenue Surprise | 5.63% |
| Release date | Nov 13, 2025 |
| EPS estimate | -$0.0700 |
| EPS actual | -$0.0100 |
| EPS Surprise | 85.71% |
| Revenue estimate | 36.445M |
| Revenue actual | 42.85M |
| Revenue Surprise | 17.58% |
| Release date | Aug 14, 2025 |
| EPS estimate | -$0.0900 |
| EPS actual | -$0.250 |
| EPS Surprise | -177.78% |
| Revenue estimate | 32.391M |
| Revenue actual | 32.544M |
| Revenue Surprise | 0.474% |
Last 4 Quarters for Evolv Technologies Holdings
Below you can see how EVLV performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 14, 2025 |
| Price on release | $7.37 |
| EPS estimate | -$0.0900 |
| EPS actual | -$0.250 |
| EPS surprise | -177.78% |
| Date | Price |
|---|---|
| Aug 08, 2025 | $7.29 |
| Aug 11, 2025 | $7.24 |
| Aug 12, 2025 | $7.50 |
| Aug 13, 2025 | $7.49 |
| Aug 14, 2025 | $7.37 |
| Aug 15, 2025 | $7.75 |
| Aug 18, 2025 | $7.99 |
| Aug 19, 2025 | $7.88 |
| Aug 20, 2025 | $7.98 |
| 4 days before | 1.10% |
| 4 days after | 8.28% |
| On release day | 5.16% |
| Change in period | 9.47% |
| Release date | Nov 13, 2025 |
| Price on release | $6.58 |
| EPS estimate | -$0.0700 |
| EPS actual | -$0.0100 |
| EPS surprise | 85.71% |
| Date | Price |
|---|---|
| Nov 07, 2025 | $7.23 |
| Nov 10, 2025 | $7.18 |
| Nov 11, 2025 | $7.04 |
| Nov 12, 2025 | $6.72 |
| Nov 13, 2025 | $6.58 |
| Nov 14, 2025 | $6.00 |
| Nov 17, 2025 | $5.76 |
| Nov 18, 2025 | $5.93 |
| Nov 19, 2025 | $5.92 |
| 4 days before | -8.99% |
| 4 days after | -10.03% |
| On release day | -8.81% |
| Change in period | -18.12% |
| Release date | Mar 10, 2026 |
| Price on release | $5.25 |
| EPS estimate | -$0.0800 |
| EPS actual | $0.0600 |
| EPS surprise | 175.00% |
| Date | Price |
|---|---|
| Mar 04, 2026 | $5.28 |
| Mar 05, 2026 | $5.19 |
| Mar 06, 2026 | $5.08 |
| Mar 09, 2026 | $5.20 |
| Mar 10, 2026 | $5.25 |
| Mar 11, 2026 | $5.75 |
| Mar 12, 2026 | $5.07 |
| Mar 13, 2026 | $5.11 |
| Mar 16, 2026 | $5.19 |
| 4 days before | -0.568% |
| 4 days after | -1.14% |
| On release day | 9.52% |
| Change in period | -1.70% |
| Release date | May 12, 2026 |
| Price on release | $6.96 |
| EPS estimate | -$0.0600 |
| EPS actual | -$0.0300 |
| EPS surprise | 50.00% |
| Date | Price |
|---|---|
| May 06, 2026 | $7.11 |
| May 07, 2026 | $7.14 |
| May 08, 2026 | $7.05 |
| May 11, 2026 | $6.92 |
| May 12, 2026 | $6.96 |
| May 13, 2026 | $6.02 |
| May 14, 2026 | $5.73 |
| May 15, 2026 | $5.70 |
| May 18, 2026 | $5.62 |
| 4 days before | -2.11% |
| 4 days after | -19.25% |
| On release day | -13.51% |
| Change in period | -20.96% |
Evolv Technologies Holdings Earnings Call Transcript Summary of Q1 2026
Evolv reported strong Q1 2026 results driven by unit deployments, new customer wins across education, healthcare, sports/venues and enterprise, and growth in product revenue from shifting to direct fulfillment of purchase subscriptions. Q1 revenue was $46.3M (up 45% YoY) and ARR was $127.3M (up 20% YoY). Adjusted EBITDA improved to $3.9M (8.5% margin). Remaining performance obligation rose to $299M (up 18% YoY). Management reiterated continued demand, raised full-year 2026 revenue guidance to $175–180M, expects ARR of ~$145–150M, and remains on track to deploy comfortably over 10,000 units by year-end. The company is transitioning more sales toward purchase subscriptions (guidance expects ~55% purchase / 45% subscription mix for the year), which increases near-term recognized revenue but shifts gross margin dynamics because of upfront hardware recognition; management expects mid-50s adjusted gross margin for the year and high-single-digit adjusted EBITDA margin for 2026. Operationally, Evolv is scaling manufacturing via a Plexus partnership, expanding AI-enabled bag screening (Expedite) adoption, investing selectively in talent, systems and controls, and expects to be cash-flow positive in H2 2026. Management will provide more detail at Investor Day on June 9, 2026.
